2021
DOI: 10.1155/2021/4234326
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Curcuma longa on Inflammatory Mediators and Immunological, Oxidant, and Antioxidant Biomarkers in Asthmatic Rats

Abstract: The effects of Curcuma longa (C. longa) on total and differential WBC, inflammatory and immunologic mediators, and oxidant and antioxidant biomarkers in bronchoalveolar lavage fluid (BALF) of rats model of asthma were assessed. Animals were divided to 5 groups including control (C), asthma (sensitized to ovalbumin), and asthmatic groups treated with 0.75, 1.50, and 3.00 mg/ml C. longa (CL) and 1.25 μg/ml dexamethasone (D) (8 rats in each group). Total and differential WBC count, concentrations of phospholipase… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 43 publications
(51 reference statements)
1
4
0
Order By: Relevance
“…An aberrant increase in IL-4 is involved in allergic responses and airway inflammation, such as in asthma. This finding is consistent with other observations of antioxidant compounds reducing the severity of asthma-like reactions [31].…”
Section: Murine Studiessupporting
confidence: 94%
“…An aberrant increase in IL-4 is involved in allergic responses and airway inflammation, such as in asthma. This finding is consistent with other observations of antioxidant compounds reducing the severity of asthma-like reactions [31].…”
Section: Murine Studiessupporting
confidence: 94%
“…An aberrant increase in IL-4 is involved in allergic responses and airway inflammation, such as in asthma. This finding is consistent with other observations of antioxidant compounds reducing the severity of asthma-like reactions [29].…”
Section: Murinesupporting
confidence: 94%
“…Treatment with C. longa (0.75, 1.50, and 3.00 mg/ml) in a rat model of asthma reduced WBC count, NO 2 , NO 3 , and MDA levels but increased SOD, CAT activities, and thiol level 47 . C. longa (0.75, 1.50, and 3.00 mg/ml) also improved total and differential WBC count, inflammatory mediators such as phospholipase A2 (PLA2) and total protein (TP), oxidative stress markers including NO 2 , NO 3 , MDA, SOD, CAT, and thiol well as IFN‐γ, IL‐4, and IgE levels in the BALF of rats model of asthma 48 …”
Section: Resultsmentioning
confidence: 97%
“…47 C. longa (0.75, 1.50, and 3.00 mg/ml) also improved total and differential WBC count, inflammatory mediators such as phospholipase A2 (PLA2) and total protein (TP), oxidative stress markers including NO 2 , NO 3 , MDA, SOD, CAT, and thiol well as IFN-γ, IL-4, and IgE levels in the BALF of rats model of asthma. 48 Clinical evidence. Administration of C. longa (30 mg/kg/ day) for 6 months reduced frequent nighttime awakenings and frequent use of short-acting β-adrenergic agonists in asthmatic patients.…”
Section: Longa Extracts and Essential Oilmentioning
confidence: 99%